右向左分流相关隐源性脑卒中的临床特点及病因的探讨
Clinical Characteristics and Etiology of Cryptogenic Stroke with Right-to-Left Shunt
摘要: 目的:探讨右向左分流(right-to-left shunt, RLS)相关隐源性脑卒中(cryptogenic stroke, CS)患者的临床特点及引起卒中的可能机制。方法:收集2018年10月至2020年9月于我院神经内科住院并根据TOAST (Trial of Org 10172 in Acute Stroke Treatment)分型诊断为CS的患者。所有CS患者均行经颅多普勒发泡试验检查,根据有无RLS,分为RLS+组和RLS−组。比较两组人口学特征、脑血管病危险因素、血小板及凝血功能,心脏的结构与功能等方面的特点。结果:共纳入111例CS患者,RLS+组55例,RLS−组56例。血管病危险因素方面,RLS+组高血压、糖尿病及高血脂比例更少(P < 0.05),而合并偏头痛、卒中、短暂性脑缺血发作(transit ischemic attack, TIA)及下肢深静脉血栓比例更多(P < 0.05)。血小板及凝血功能方面,RLS+组平均血小板体积(11.34 ± 1.34 vs 10.29 ± 0.82, P < 0.001)、D-二聚体含量(965.27 ± 1609.90 vs 320.54 ± 175.38, P = 0.004)均显著高于RLS−组。心脏结构与功能方面,RLS+组左房前后径(4.03 ± 0.40 vs 3.69 ± 0.34, P < 0.001)、肺动脉收缩压(30.82 ± 7.31 vs 28.48 ± 4.14, P = 0.040)均大于RLS−组。结论:伴RLS的CS患者血管病危险因素少见,但偏头痛、卒中、TIA、下肢深静脉血栓及肺动脉高压病史多见。伴RLS的CS发病可能与RLS患者存在血小板活化、血液高凝、左房扩大有关。
Abstract: Objective: To explore the clinic characteristics and pathogenesis of cryptogenic stroke (CS) patients with right-to-left shunt (RLS). Methods: Patients admitted to the Department of Neurology of our hospital from October 2018 to September 2020 and diagnosed as CS according to TOAST classification were enrolled. All CS patients were examined by contrast-enhanced transcranial Doppler test, and were divided into RLS+ group and RLS− group according to the existence of RLS. Demographic characteristics, risk factors of vascular disease, platelet function, coagulation function, structure and function of heart were compared between two groups. Results: A total of 111 CS patients were enrolled, 55 patients in RLS+ group and 56 patients in RLS− group. In terms of risk factors of vascular disease, RLS+ group had less prevalence of hypertension, diabetes and hyperlipidemia (P < 0.05), but more prevalence of migraine, stroke, transit ischemic attack (TIA) and lower limb venous thrombosis (P < 0.05). In terms of platelet and coagulation function, the average platelet volume (11.34 ± 1.34 vs 10.29 ± 0.82, P < 0.001) and D-Dimer content (965.27 ± 1609.90 vs 320.54 ± 175.38, P = 0.004) were higher in the RLS+ group than the RLS− group. In terms of the structure and function of the heart, left atrial diameter (4.03 ± 0.40 vs 3.69 ± 0.34, P < 0.001) and pulmonary arterial systolic pressure (30.82 ± 7.31 vs 28.48 ± 4.14, P = 0.040) were higher in the RLS+ group than the RLS− group. Conclusions: Risk factors for vascular disease are rare in CS patients with RLS, but a history of migraine, stroke, TIA, deep venous thrombosis in the lower extremities, and pulmonary arterial hypertension is more common. The incidence of CS with RLS may be related to platelet activation, blood hypercoagul ability and left atrial enlargement in patients with RLS.
文章引用:王敏, 赵洪芹, 何香芹, 解倩倩, 魏凌. 右向左分流相关隐源性脑卒中的临床特点及病因的探讨[J]. 临床医学进展, 2021, 11(2): 482-489. https://doi.org/10.12677/ACM.2021.112069

参考文献

[1] Yaghi, S., Bernstein, R.A., Passman, R., et al. (2017) Cryptogenic Stroke: Research and Practice. Circulation Research, 120, 527-540. [Google Scholar] [CrossRef
[2] Guercini, F., Acciarresi, M., Agnelli, G., et al. (2008) Cryptogenic Stroke: Time to Determine Aetiology. Journal of Thrombosis and Haemostasis, 6, 549-554. [Google Scholar] [CrossRef] [PubMed]
[3] Piechowski-Jozwiak, B. and Bogousslavsky, J. (2013) Stroke and Patent Foramen Ovale in Young Individuals. European Neurology, 69, 108-117. [Google Scholar] [CrossRef] [PubMed]
[4] Geva, T., Martins, J.D. and Wald, R.M. (2014) Atrial Septal Defects. The Lancet, 383, 1921-1932. [Google Scholar] [CrossRef
[5] Ioannidis, S.G. and Mitsias, P.D. (2020) Patent Foramen Ovale in Cryptogenic Ischemic Stroke: Direct Cause, Risk Factor, or Incidental Finding? Frontiers in Neurology, 11, 567. [Google Scholar] [CrossRef] [PubMed]
[6] Adams Jr., H.P., et al. (1993) Classification of Subtype of Acute Ischemic Stroke. Definitions for Use in a Multicenter Clinical Trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24, 35-41. [Google Scholar] [CrossRef
[7] Wang, S.B., Liu, K.D., Yang, Y., et al. (2018) Prevalence and Extent of Right-to-Left Shunt on Contrast-Enhanced Transcranial Doppler in Chinese Patients with Migraine in a Multicentre Case-Control Study. Cephalalgia, 38, 690-696. [Google Scholar] [CrossRef] [PubMed]
[8] Mahfouz, R.A., Alawady, W.S., Salem, A., et al. (2017) Atrial Dyssynchrony and Left Atrial Stiffness Are Risk Markers for Cryptogenic Stroke in Patients with Patent Foramen Ovale. Echocardiography, 34, 1888-1894. [Google Scholar] [CrossRef] [PubMed]
[9] Lamy, C., Giannesini, C., Zuber, M., et al. (2002) Clinical and Imaging Findings in Cryptogenic Stroke Patients with and without Patent Foramen Ovale: The PFO-ASA Study. Atrial Septal Aneurysm. Stroke, 33, 706-711. [Google Scholar] [CrossRef] [PubMed]
[10] Ling, Y., Wang, M., Pan, X., et al. (2020) Clinical Features of Right-to-Left Shunt in the Different Subgroups of Migraine. Brain and Behavior, 10, e01553. [Google Scholar] [CrossRef] [PubMed]
[11] He, D., Li, Q., Xu, G., et al. (2018) Clinical and Imaging Characteristics of PFO-Related Stroke with Different Amounts of Right-to-Left Shunt. Brain and Behavior, 8, e01122. [Google Scholar] [CrossRef] [PubMed]
[12] Kent, D.M., Thaler, D.E. and Ro, P.E.S.I. (2011) The Risk of Paradoxical Embolism (RoPE) Study: Developing Risk Models for Application to Ongoing Randomized Trials of Percutaneous Patent Foramen Ovale Closure for Cryptogenic Stroke. Trials, 12, 185. [Google Scholar] [CrossRef] [PubMed]
[13] Tuder, R.M., Archer, S.L., Dorfmuller, P., et al. (2013) Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension. Journal of the American College of Cardiology, 62, D4-D12. [Google Scholar] [CrossRef] [PubMed]
[14] Mojadidi, M.K., Ruiz, J.C., Chertoff, J., et al. (2019) Patent Foramen Ovale and Hypoxemia. Cardiology in Review, 27, 34-40. [Google Scholar] [CrossRef
[15] Duzel, B., Eren, N.K., Berilgen, R., et al. (2014) Decline in Mean Platelet Volume in Patients with Patent Foramen Ovale Undergoing Percutaneous Closure. Cardiovascular Journal of Africa, 25, 165-167. [Google Scholar] [CrossRef
[16] Borgdorff, P. and Tangelder, G.J. (2012) Migraine: Possible Role of Shear-Induced Platelet Aggregation with Serotonin Release. Headache, 52, 1298-1318. [Google Scholar] [CrossRef] [PubMed]
[17] Ozdemir, A.O., Tamayo, A., Munoz, C., et al. (2008) Cryptogenic Stroke and Patent Foramen Ovale: Clinical Clues to Paradoxical Embolism. Journal of the Neurological Sciences, 275, 121-127. [Google Scholar] [CrossRef] [PubMed]
[18] Rigatelli, G., Roncon, L., Braggion, G., et al. (2006) Deep Venous Thrombosis before Patent Foramen Ovale Closure. The American Journal of Medicine, 119, 97-98. [Google Scholar] [CrossRef] [PubMed]
[19] Pezzini, A., Del Zotto, E., Magoni, M., et al. (2003) Inherited Thrombophilic Disorders in Young Adults with Ischemic Stroke and Patent Foramen Ovale. Stroke, 34, 28-33. [Google Scholar] [CrossRef
[20] Lichy, C., Padovani, A., Magoni, M., et al. (2017) Do Common Prothrombotic Mutations Influence the Risk of Cerebral Ischaemia in Patients with Patent Foramen Ovale? Thrombosis and Haemostasis, 101, 813-817. [Google Scholar] [CrossRef
[21] Saver, J.L., Carroll, J.D., Thaler, D.E., et al. (2017) Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. The New England Journal of Medicine, 377, 1022-1032. [Google Scholar] [CrossRef
[22] Sardana, M., Lessard, D., Tsao, C.W., et al. (2018) Association of Left Atrial Function Index with Atrial Fibrillation and Cardiovascular Disease: The Framingham Offspring Study. Journal of the American Heart Association, 7, e008435. [Google Scholar] [CrossRef
[23] Leifer, D. and Rundek, T. (2019) Atrial Cardiopathy. Neurology, 92, 155-156. [Google Scholar] [CrossRef
[24] Hoit, B.D. (2014) Left Atrial Size and Function: Role in Prognosis. Journal of the American College of Cardiology, 63, 493-505. [Google Scholar] [CrossRef] [PubMed]
[25] Xu, Y., Zhao, L., Zhang, L., et al. (2020) Left Atrial Enlargement and the Risk of Stroke: A Meta-Analysis of Prospective Cohort Studies. Frontiers in Neurology, 11, 26. [Google Scholar] [CrossRef] [PubMed]
[26] Yaghi, S., Moon, Y.P., Mora-Mclaughlin, C., et al. (2015) Left Atrial Enlargement and Stroke Recurrence: The Northern Manhattan Stroke Study. Stroke, 46, 1488-1493. [Google Scholar] [CrossRef
[27] Hamatani, Y., Ogawa, H., Takabayashi, K., et al. (2016) Left Atrial Enlargement Is an Independent Predictor of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation. Scientific Reports, 6, Article No. 31042. [Google Scholar] [CrossRef] [PubMed]
[28] Lee, M.J., Park, S.J., Yoon, C.H., et al. (2016) Association of Left Atrial Enlargement with Cortical Infarction in Subjects with Patent Foramen Ovale. Journal of Stroke, 18, 304-311. [Google Scholar] [CrossRef] [PubMed]
[29] Rigatelli, G., Zuin, M., Adami, A., et al. (2019) Left Atrial Enlargement as a Maker of Significant High-Risk Patent Foramen Ovale. The International Journal of Cardiovascular Imaging, 35, 2049-2056. [Google Scholar] [CrossRef] [PubMed]
[30] Anaissie, J., Monlezun, D., Seelochan, A., et al. (2016) Left Atrial Enlargement on Transthoracic Echocardiography Predicts Left Atrial Thrombus on Transesophageal Echocardiography in Ischemic Stroke Patients. BioMed Research International, 2016, Article ID: 7194676. [Google Scholar] [CrossRef] [PubMed]
[31] Mariucci, E., Donti, A., Salomone, L., et al. (2017) Recurrent Stroke after Transcatheter PFO Closure in Cryptogenic Stroke or Tia: Long-Term Follow-Up. Cardiology Research and Practice, 2017, Article ID: 9849425. [Google Scholar] [CrossRef] [PubMed]
[32] Tateishi, Y., Kanamoto, T., Yamashita, K., et al. (2019) Biomarkers of Cardiac Dysfunction as Risk Factors in Cryptogenic Stroke. Cerebrovascular Diseases, 48, 132-139. [Google Scholar] [CrossRef] [PubMed]
[33] Berthet, K., Lavergne, T., Cohen, A., et al. (2000) Significant Association of Atrial Vulnerability with Atrial Septal Abnormalities in Young Patients with Ischemic Stroke of Unknown Cause. Stroke, 31, 398-403. [Google Scholar] [CrossRef
[34] Cotter, P.E., Martin, P.J., Pugh, P.J., et al. (2011) Increased Incidence of Interatrial Block in Younger Adults with Cryptogenic Stroke and Patent Foramen Ovale. Cerebrovascular Diseases Extra, 1, 36-43. [Google Scholar] [CrossRef] [PubMed]
[35] Lee, P.H., Song, J.K., Kim, J.S., et al. (2018) Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial. Journal of the American College of Cardiology, 71, 2335-2342. [Google Scholar] [CrossRef] [PubMed]